New combo therapy for bacterial vaginosis shows promise in clinical trial
NCT ID NCT07247851
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a vaginal clindamycin cream to standard oral metronidazole works better than oral metronidazole alone for treating bacterial vaginosis. One hundred women with confirmed BV took part. The goal was to see if the combination relieved symptoms like discharge and odor more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams Maternity Hospital
Cairo, Abbasia, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Friendly bacteria vs. vaginal infections: a new trial puts probiotics to the test
- Can a simple Self-Test cut preterm births in High-Risk pregnancies?
- Vaginal device aims to boost infection treatment
- Blue light could soothe vaginal disorders without hormones
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- Can a probiotic stop bacterial vaginosis recurrence?